logo

GLMD

GalmedยทNASDAQ
--
--(--)
--
--(--)

GLMD Profile

Galmed Pharmaceuticals Ltd.

A clinical-stage biopharmaceutical company that focused on liver, metabolic, fibrosis and inflammatory diseases

Pharmaceutical
07/31/2013
03/13/2014
NASDAQ Stock Exchange
3
12-31
Common stock
16 Abba Hillel Road, Ramat Gan, Israel 5250608
--
Galmed Pharmaceuticals Ltd., incorporated in Israel on July 31, 2013, is an Israeli private company. The company is currently working on advancing the development of Aramchol as a combination therapy for the treatment of gastrointestinal tumors. As part of its growth strategy, the company actively seeks opportunities in biotechnology and medical technology to expand and enrich its product line, with a particular focus on gastrointestinal and cardiovascular metabolic diseases, as well as other innovative product candidates in line with its core competencies.